Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Psychiatry
•
Child & Adolescent Psychiatry
•
General Psychiatry
When would you consider transdermal treatments for ADHD?
Related Questions
When do you use SNRIs or norepinephrine reuptake inhibitors (e.g., atomoxetine) for the treatment of ADHD?
What pharmacological management to you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
How reliable do you find it to make the diagnosis of bipolar disorder based on a patient report of prior symptoms or questionnaire and not the actual observation of hypo/mania on the exam?
How do you approach anxiety management for patients who have been on long-term (years or more) daily benzodiazepines?
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
When do you consider lamotrigine in bipolar depression?
How do you manage obsessive-compulsive disorder refractory to high-dose SSRI and cognitive behavioral therapy?
What pharmacologic therapy, if any, do you recommend for treatment of borderline personality disorder?
What do you do when a patient experiences multiple rounds of antidepressant-related tachyphylaxis?
How do you manage emotional blunting due to SSRIs/SNRIs?
